Stock ALEXZA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Alexza Pharmaceuticals, Inc. Stock

Equities

US0153842093

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Alexza Pharmaceuticals, Inc.

Press releases Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results PU
Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016 PU
Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination PU
Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent PU
Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder PU
More press releases

News in other languages on Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals : Les valeurs à suivre sur les marchés américains
More news

Managers and Directors - Alexza Pharmaceuticals, Inc.

Managers TitleAgeSince
Stacy Palermini DFI
 Director of Finance/CFO - 02-12-31
Tatjana Naranda PSD
 President - 04-12-31
Wolfgang Schmidt PRN
 Corporate Officer/Principal - 19-04-30
Members of the board TitleAgeSince
Jorge Ramentol Massana BRD
 Director/Board Member - 16-06-20
Joan Fanés Trillo BRD
 Director/Board Member - 16-06-20
Sergio Ferrer-Salat Serra di Migni BRD
 Director/Board Member - 16-06-20
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock